0105
Autoimmune
Synexa specialises in biomarker and bioanalytical services which can be specifically tailored to suit both the modality of the therapeutic and the disease area of focus. Autoimmune conditions are highly heterogenous, affecting numerous cell types, molecular pathways and tissues, necessitating multi-pronged approaches integrating technology platforms including targeted genetic analysis, soluble biomarkers and flow cytometry.
Autoimmune
01
0205
Oncology
Synexa’s expertise in the field of immunology and immune-based analytical technologies makes us the perfect partner in advancing oncology therapeutic pipelines. We use innovative approaches and validated platforms to answer client-specific questions for quality, clinically-relevant data.
Oncology
02
0305
Vaccines
Accelerate vaccine development and evaluation with our comprehensive suite of bioanalytical services, supporting safety, immunogenicity, and efficacy assessments for a wide range of vaccine candidates.
Vaccines
03
0405
Cell & Gene Therapy
Advanced bioanalytical solutions for cell and gene therapies, providing comprehensive characterization, quantification, and safety assessment to support the development of innovative treatment approaches.
Cell & Gene Therapy
04
0505
Biosimilars
Robust analytical solutions for biosimilar development, offering comparative bioanalysis, potency assays, and structural characterization to ensure similarity to reference biologics and meet regulatory requirements.
Biosimilars
05
